162 related articles for article (PubMed ID: 30547008)
1. Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.
Jhaveri J; Cheng E; Tian S; Buchwald Z; Chowdhary M; Liu Y; Gillespie TW; Olson JJ; Diaz AZ; Voloschin A; Eaton BR; Crocker IR; McDonald MW; Curran WJ; Patel KR
Front Oncol; 2018; 8():440. PubMed ID: 30547008
[No Abstract] [Full Text] [Related]
2. Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu HG; Crocker IR; Curran WJ; Patel KR
Cancer; 2018 Mar; 124(6):1169-1178. PubMed ID: 29205287
[TBL] [Abstract][Full Text] [Related]
3. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
[TBL] [Abstract][Full Text] [Related]
4. Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients-results of KRANIOPHARYNGEOM 2007.
Friedrich C; Boekhoff S; Bischoff M; Beckhaus J; Sowithayasakul P; Calaminus G; Eveslage M; Valentini C; Bison B; Harrabi SB; Krause M; Timmermann B; Müller HL
Front Oncol; 2023; 13():1180993. PubMed ID: 37965466
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Adjuvant Radiation Therapy Alone and Chemotherapy Alone in Surgically Resected Low-Grade Gliomas: Survival Analyses of 2253 Cases from the National Cancer Data Base.
Wu J; Neale N; Huang Y; Bai HX; Li X; Zhang Z; Karakousis G; Huang R; Zhang PJ; Tang L; Xiao B; Yang L
World Neurosurg; 2018 Apr; 112():e812-e822. PubMed ID: 29409888
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.
Saeed AM; Khairnar R; Sharma AM; Larson GL; Tsai HK; Wang CJ; Halasz LM; Chinnaiyan P; Vargas CE; Mishra MV
Adv Radiat Oncol; 2020; 5(5):978-983. PubMed ID: 33083661
[TBL] [Abstract][Full Text] [Related]
7. Transitioning from conventional photon therapy to proton therapy for primary brain tumors.
Ek H; Fagerström Kristensen I; Stenberg L; Kinhult S; Benedek H; Ek S; Engelholm SA; Engelholm S; Munck Af Rosenschöld P
Acta Oncol; 2023 Apr; 62(4):391-399. PubMed ID: 37203198
[TBL] [Abstract][Full Text] [Related]
8. Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.
Damen PJJ; van Rossum PSN; Chen Y; Abana CO; Liao Z; Hobbs BP; Mohan R; Blum-Murphy M; Hofstetter WL; Lin SH
Int J Part Ther; 2024 Mar; 11():100012. PubMed ID: 38757082
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and Toxicities of Proton and Photon Radiation Therapy for Testicular Seminoma.
Pasalic D; Prajapati S; Ludmir EB; Tang C; Choi S; Kudchadker R; Frank SJ
Int J Part Ther; 2020; 7(2):11-20. PubMed ID: 33274253
[TBL] [Abstract][Full Text] [Related]
10. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.
Xi M; Xu C; Liao Z; Chang JY; Gomez DR; Jeter M; Cox JD; Komaki R; Mehran R; Blum MA; Hofstetter WL; Maru DM; Bhutani MS; Lee JH; Weston B; Ajani JA; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):667-676. PubMed ID: 29280461
[TBL] [Abstract][Full Text] [Related]
11. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review.
Verma V; Lin SH; Simone CB; Mehta MP
J Gastrointest Oncol; 2016 Aug; 7(4):644-64. PubMed ID: 27563457
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
14. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.
Amini A; Raben D; Crawford ED; Flaig TW; Kessler ER; Lam ET; Maroni P; Pugh TJ
Urol Oncol; 2017 Jun; 35(6):438-446. PubMed ID: 28214281
[TBL] [Abstract][Full Text] [Related]
15. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
16. Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States.
Haque W; Verma V; Butler EB; Teh BS
J Gastrointest Oncol; 2018 Apr; 9(2):282-294. PubMed ID: 29755767
[TBL] [Abstract][Full Text] [Related]
17. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
[TBL] [Abstract][Full Text] [Related]
19. Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer.
Suh YG; Noh JM; Lee DY; Kim TH; Bayasgalan U; Pyo H; Moon SH
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892885
[TBL] [Abstract][Full Text] [Related]
20. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
